Page 1

Report: Brain Cancer - Pipeline Review, H1 2014 Category: Healthcare

Insert Image Height - 3.60 Width – 4.98

Report: Brain Cancer - Pipeline Review, H1 2014 Report Coverage

• Snapshot of the global therapeutic landscape of Brain Cancer • Review of key pipeline products under drug profile section • Review of key players involved in the therapeutics development for

brain cancer and enlists all their major and minor projects • Summary of all the dormant and discontinued pipeline projects • Review of the brain cancer products under development by companies and universities or research institutes based on information derived from company and industry-specific sources • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

Report: Brain Cancer - Pipeline Review, H1 2014 Report Coverage (Continued)

• A detailed assessment of monotherapy and combination therapy pipeline projects • Coverage of the brain cancer pipeline on the basis of target, MoA,

route of administration and molecule type • Latest news and deals relating related to pipeline products

Report: Brain Cancer - Pipeline Review, H1 2014 Report Benefits

• Strategically significant competitor information, analysis, and insights assist in formulation of effective R&D development strategies • Identify emerging players with potentially strong product portfolio

and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Brain Cancer • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Report: Brain Cancer - Pipeline Review, H1 2014 Report Benefits (Continued)

• Devise corrective measures for pipeline projects by understanding brain cancer pipeline depth and focus of Indication therapeutics • Develop and design in-licensing and out-licensing strategies by

identifying prospective partners with the most attractive projects to enhance and expand business potential and scope • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Report: Brain Cancer - Pipeline Review, H1 2014 Table of Contents

• • • • • • • • • • •

Introduction Brain Cancer Overview Therapeutics Development Pipeline Products for Brain Cancer Therapeutics under Development by Companies Therapeutics under Investigation by Universities or Institutes Pipeline Products Glance Dormant Projects Discontinued Products Product Development Milestones Appendix

Report: Brain Cancer - Pipeline Review, H1 2014 Report Details

• • • • • • • • •

Publish date: Feb 28, 2014 Number of slides: 137 Geographic coverage: Global Available format: PDF, CD, Hardcopy Price for Single User License: USD 2,000 Price for Site License: USD 4,000 Price for Global User License: USD 6,000 Delivery Time: Within 1 business day Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google Wallet, PayPal

Interested in this report? To view more details regarding this premium market research report, Please click here

For further information, get in touch with us: E-mail: Call: US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600 About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports Industry Segments Automotive & Transport

Consumer goods


Food and Beverage

Energy and Utilities

Public Sector

Manufacturing & Construction


Media & Entertainment

IT, Telecom & Electronics



Emerging players with potentially strong product portfolio to capture brain cancer market  

For the complete report ,visit us at: Or, get in touch with us at : customerservice@researchonglobalmarket...

Read more
Read more
Similar to
Popular now
Just for you